Storys zum Thema Krankheit

Technische Universität München

New X-ray technology can improve Covid-19 diagnosis

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Images: https://mediatum.ub.tum.de/1692790 NEWS RELEASE New X-ray technology can improve Covid-19 diagnosis Patient study demonstrates benefits of dark-field X-ray technology A research team at the Technical University of Munich (TUM) has, for the first time, produced dark-field X-ray images of ...

Technische Universität München

Why are overweight people more susceptible to illness?

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22778 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/warum-bekommen-uebergewichtige-menschen-haeufiger-erkrankungen Picture: https://mediatum.ub.tum.de/1612044 NEWS RELEASE Why are overweight people more susceptible to illness? Size of fat cells can cause ...

R-Biopharm AG

Flu tests from R-Biopharm also detect new virus variants

RHEACELL GmbH und Co. KG

Stem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research

Technische Universität München

Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22779 - email: presse@tum.de - web: www.tum.de Image download: https://mediatum.ub.tum.de/652209?show_id=1691364 NEWS RELEASE Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid ...

Klinik für Prostata-Therapie Heidelberg

Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment

Helmholtz Zentrum München

Type 1 diabetes: New findings on the development of the autoimmune disease in children

Helmholtz Zentrum München

Switching tracks: Changing the trafficking of the glucagon receptor in the liver regulates its metabolic signaling

benfovir AG

benfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)

Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...

Helmholtz Zentrum München

Landscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cells

Technische Universität München

Improved monitoring of silicone implants

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10808 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/aktuelles/alle-meldungen/pressemitteilungen/details/verbessertes-monitoring-von-silikonimplantaten Pictures: https://mediatum.ub.tum.de/1687409 NEWS RELEASE Improved monitoring of silicone implants New algorithm for clinical MRI scanners makes breast ...

European Society for Medical Oncology (ESMO)

ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability

Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...

Helmholtz Zentrum München

Efficient AI technology for MRI data analysis

Helmholtz Zentrum München

2

Vitamin K prevents cell death: a new function for a long-known molecule

Technische Universität München

Viruses help combat antibiotic-resistant bacteria - Cell-free production of bacteriophages

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37533 High resolution images: https://mediatum.ub.tum.de/1678288 NEWS RELEASE Viruses help combat ...

R-Biopharm AG

R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories

Technische Universität München

New center for digital medicine and health

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37491 Images: https://mediatum.ub.tum.de/1663381 NEWS RELEASE Interdisciplinary research for the digital medicine of the future Federal and state governments approve funding for digital medicine and health center ...

News Direct

UK MEDTECH COMPANY TO HELP PROTECT US HEALTHCARE WORKERS AND US CITIZENS FROM 1 MILLON NEEDLESTICK INJURIES EACH YEAR

Liverpool England and Philadelphia USA (ots) - --News Direct-- SAFETY INITIATIVE AND COMPLIANCE WILL SAVE AMERICAN HEALTHCARE INDUSTRY $1 BILLION British smart MedTech company NeedleSmart, which is pioneering disruptive technologies in the global healthcare sector, is expanding into the US healthcare market to ...

benfovir AG

benfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS

Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...

European Patent Office (EPO)

European Inventor Award 2022: Meet the inventors that are shaping our world at virtual event

Munich (ots) - - The winners of the European Patent Office’s annual innovation prize will be revealed at a ceremony on 21 June 2022 at 12:00 CEST held in an all-new format - Discover the stories of 14 exceptional inventor teams and 4 young innovators from 14 countries - The public is now invited to vote for their favourite inventor to win the Popular Prize at ...

News Direct

ALDERHEY@NYWHERE(TM)

Liverpool, England (ots) - CREATING A HOSPITAL OF THE FUTURE: "A HOSPITAL WITHOUT WALLS" ALDER HEY LAUNCHES GROUND-BREAKING HYBRID DIGITAL HEALTH PLATFORM IN COLLABORATION WITH MICROSOFT AND MINDWAVE "TODAY'S CHILD, TOMORROW'S HEALTHIER ADULT" Alder Hey Children's NHS Foundation Trust, one of the world's leading paediatric healthcare institutions, has today launched a ground-breaking digital platform that is set to revolutionise the way in which patient care is delivered to ...

R-Biopharm AG

R-Biopharm announces test to detect monkeypox virus

Technische Universität München

Same symptom – different cause? Algorithms help to distinguish diseases at the molecular level

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37411 High resolution images: https://mediatum.ub.tum.de/1659820 NEWS RELEASE Same symptom – different cause? Algorithms help to distinguish diseases at the ...

Technische Universität München

A repair program for the heart

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22731 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37376 Images: https://mediatum.ub.tum.de/1658419 NEWS RELEASE A repair program for the heart Cardiac progenitor cells generate healthy tissue after a heart attack Following a heart attack, the human body is incapable of repairing lost tissue due to the heart’s ...

Technische Universität München

Vaccination campaign messages often prove ineffective

TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de NEWS RELEASE Vaccination campaign messages often prove ineffective Study in eight countries demonstrates barriers for communications on Covid-19 Conventional vaccination campaign messages often miss their targets. A study in eight European countries shows that information on the benefits of ...

CBmed GmbH

Is microplastic carcinogenic?

Graz/Vienna (ots) - The effects of micro- and nanoplastic particles (MNP) in the human body are being investigated in depth for the first time worldwide. From 2022 to 2025, research will be performed at CBmed together with international partners to elucidate potential health effects of microplastics. Every person in developed countries currently ingests an average of five grams of plastics per week - that's as much as a standard credit card. What these micro- and nanoplastic ...

Fördergesellschaft IZB mbH

Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio

Lemon from Spain

Why is it advisable to use lemon vitamin C during the winter?

EcoCare

2

Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats

Technische Universität München

Overcoming resistance of pancreatic cancer to immunotherapies

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37173 High resolution images: https://mediatum.ub.tum.de/1641984 NEWS RELEASE “Inflaming” cold tumors Overcoming resistance of pancreatic cancer to immunotherapies Pancreatic carcinoma is a ...